These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3363659)

  • 1. Generation and characterization of cyclosporine metabolites produced in a hepatic microsomal system.
    Cheung F; Wong PY; Cole E; Cohen Z; Levy GA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):633-6. PubMed ID: 3363659
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of cyclosporine.
    Maurer G
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):19-26. PubMed ID: 3895660
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of cyclosporine and 18 metabolites in blood, bile, and urine by high-performance liquid chromatography.
    Christians U; Schlitt HJ; Bleck JS; Schiebel HM; Kownatzki R; Maurer G; Strohmeyer SS; Schottmann R; Wonigeit K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):609-13. PubMed ID: 3284110
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine metabolites suppress T cell proliferation induced by concanavalin A.
    Dindzans VJ; Wong PY; Mee AV; Cheung F; Abecassis M; Cole EH; Cohen Z; Levy GA
    Transplant Proc; 1987 Aug; 19(4):3490-3. PubMed ID: 3303521
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation, characterization and in vitro activity of human cyclosporin A metabolites.
    Wallemacq PE; Lhoëst G; Latinne D; De Bruyère M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):906-10. PubMed ID: 2650295
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.
    Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA
    Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of cyclosporine metabolites in therapeutic monitoring and immunosuppression.
    Rosano TG; Freed BM; Pell MA; Dybas MT; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1699-703. PubMed ID: 2950633
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of cyclosporine A dosage and metabolism in liver and heart transplant recipients.
    Hamilton G; Mühlbacher F; Roth E; Wolf I; Piza F; Havel M; Laczkovics A; Schindler J; Wolosczuk W
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1706-8. PubMed ID: 3547878
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologic significance of cyclosporine metabolites.
    Ryffel B; Foxwell BM; Mihatsch MJ; Donatsch P; Maurer G
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):575-84. PubMed ID: 3363656
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.
    Hartman NR; Jardine I
    Drug Metab Dispos; 1987; 15(5):661-4. PubMed ID: 2891483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses.
    Freed BM; Stevens C; Zhang G; Rosano TG; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):233-9. PubMed ID: 3284070
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line.
    Freed BM; Stevens C; Brooks C; Cramer S; Lempert N; Rosano TG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):980-1. PubMed ID: 1989352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunopharmacology of cyclosporin A].
    Nikitin AV
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):56-66. PubMed ID: 2418777
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).
    Nicoll-Griffith DA; Chauret N; Yergey JA; Trimble LA; Favreau L; Zamboni R; Grossman SJ; Drey J; Herold E
    Drug Metab Dispos; 1993; 21(5):861-7. PubMed ID: 7902249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of an optimal assay method for monitoring cyclosporine therapy.
    Rosano TG; Brooks CA; Dybas MT; Cramer SM; Stevens C; Freed BM
    Transplant Proc; 1990 Jun; 22(3):1125-8. PubMed ID: 2349672
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
    MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro biotransformation of xanthohumol, a flavonoid from hops (Humulus lupulus), by rat liver microsomes.
    Yilmazer M; Stevens JF; Deinzer ML; Buhler DR
    Drug Metab Dispos; 2001 Mar; 29(3):223-31. PubMed ID: 11181488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of native cyclosporine over metabolites in rat blood and tissue.
    Pell MA; Rosano TG; Brayman KL; Freed BM; Shaw LM; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):674-9. PubMed ID: 3363664
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotransformation of lithocholic acid by rat hepatic microsomes: metabolite analysis by liquid chromatography/mass spectrometry.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2008 Feb; 36(2):442-51. PubMed ID: 18039809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.